Do Markers of Systemic Inflammatory Response and Tumor Metabolism Indicate Radioresistance in Head and Neck Cancer?
Condition: Head and Neck Squamous Cell Carcinoma Intervention: Radiation: Radiochemotherapy Sponsors: Luzerner Kantonsspital; University of Lucerne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 1, 2022 Category: Research Source Type: clinical trials
